Sources: Thrive invested $1B in OpenAI in 2025 at a $285B valuation in a transaction akin to a call option; OpenAI was separately raising at a $830B valuation
Context & Ripple Effects
Thrive’s relationship with OpenAI has repeatedly combined primary financing with tailored access: in 2024 it backed a major round with an option to invest additional capital at the prior valuation. Earlier, it also led an employee-liquidity transaction when OpenAI was valued at $80 billion or more.
The reported 2025 structure places a lower-valuation, option-like investment alongside a separate fundraising process at a much higher valuation. That contrast makes deal terms—not just the headline valuation—central to understanding OpenAI’s capital formation.
First-order effects
- Thrive obtains $1 billion of exposure to OpenAI through a structure tied to a $285 billion valuation, distinct from the company’s separately reported $830 billion fundraising valuation.
- OpenAI adds another customized financing arrangement to a capital base that had already included more than $1 billion from Thrive in its 2024 round.
Second-order effects
- Other prospective OpenAI investors may have to assess which valuation, liquidity rights, and option terms apply to their own entry, rather than treating a single headline valuation as the full price of access.
- The deal reinforces the advantage of established backers that can negotiate bespoke structures, while newer investors may face a more standardized—and potentially costlier—route into scarce frontier-lab equity.
Third-order effects
- If such structures become routine, frontier AI financing could be priced through a mix of options, secondary liquidity, and primary rounds rather than a single clean valuation benchmark.
- That would deepen capital concentration around a small group of labs and repeat investors, while making valuation comparisons across AI deals less straightforward.
The trend: This is another instance of frontier-lab capital concentration, in which access to leading AI companies is increasingly shaped by bespoke financing terms as much as by stated valuations.